About the Schizophrenia Session
A mental illness known as schizophrenia is characterised by recurrent or ongoing psychotic episodes. Hallucinations (which generally involve hearing voices), delusions, and disordered thinking are among the main symptoms. Apathy, reduced emotional expressiveness, and social disengagement are further signs. Symptoms often start in early adulthood, come on gradually, and in many cases never go away. The diagnosis is based on observable behaviour, a history that includes the individual's stated experiences, and observations from those who are familiar with the person; there is no objective diagnostic test. Symptoms and functional impairment must be present for six months (DSM-5) or one month in order to be diagnosed with schizophrenia (ICD-11). In particular, drug use disorders, depressive disorders, anxiety disorders, and obsessive-compulsive disorder are frequently present in patients with schizophrenia.
Topics Covered in Schizophrenia
Psychotic episodes, hallucinations and delusions
Negative symptoms and social withdrawal
Early intervention in first-episode psychosis
Diagnostic criteria and clinical assessment
Antipsychotic treatment and psychosocial therapies
Comorbid substance use and mood disorders
Featured Speakers — Schizophrenia 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Schizophrenia Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at IPHC 2027
Why Attend the Schizophrenia Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Schizophrenia work, reviewed by the scientific committee.
Network Globally
Meet public health researchers, educators, and policy leaders from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Schizophrenia research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IPHC 2027 for the Schizophrenia track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Schizophrenia Conference 2027 — FAQs
What is the Schizophrenia track at IPHC 2027?
The Schizophrenia track is a dedicated stream within IPHC 2027 covering the latest research, innovation, and best practice in Schizophrenia. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Schizophrenia sessions?
Public health researchers, practitioners, epidemiologists, educators, doctoral students, and policy leaders with an interest in Schizophrenia are all welcome — whether presenting or attending.
Can I present my research in the Schizophrenia track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Schizophrenia sessions?
Yes. IPHC 2027 is a hybrid conference — attend the Schizophrenia track in person in Singapore or join live online, with on-demand access afterward.
Join the IPHC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.